期刊档案 · Immunology and Microbiology-Immunology
Immune Network
ISSN 1598-2629 · eISSN 2092-6685 · Korean Association of Immunologists · South Korea
Immune Network 中科院 医学 4区（2025 年升级版），影响因子 5.81，完全开放获取，APC 约 1,000 美元，近 24 个月 78 篇文章投稿到接收中位 63 天，2025 年发文 44 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Immune Network 由 Korean Association of Immunologists 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Immune Cell Function and Interaction、Immunotherapy and Immune Responses、T-cell and B-cell Immunology 等主题的论文，这 3 个主题约占 44.3%，主导子领域为 Immunology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Since 2001, Immune Network (ISO abbreviation: Immune Netw.) is the official journal of the Korean Association of Immunologists (KAI). Immune Network publishes peer-reviewed articles that report novel findings in basic and clinical immunology. The journal publishes full-length articles, brief communications, reviews and technique reports. The journal is published online only in English and bimonthly on the last days of February, April, June, August, October, and December. All submissions, reviews, and decisions are processed on-line (https://immunenetwork.org). Also, full-text is freely available from the same web site (https://immunenetwork.org). This journal was supported by the Korean Federation of Science and Technology Societies Grant funded by the Korean Government(Ministry of Education). Immune Network is indexed/tracked/covered by Science Citation Index Expanded (SCIE), PubMed, PubMed Central, KoreaMed, Synapse, KoMCI, Crossref, SCOPUS, EMBASE and Google Scholar. ·
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Immunology and Microbiology-Immunology
主编 Chong-Kil Lee出版商官网
编委会国家分布：中国大陆 2 位（约 3%）；主要国家 韩国 40、美国 16、日本 5、中国 2、德国 2（共 72 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Immune Cell Function and InteractionImmunology and Microbiology18.7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology13%
- T-cell and B-cell ImmunologyImmunology and Microbiology12.6%
- Immune Response and InflammationImmunology and Microbiology6.2%
- Monoclonal and Polyclonal Antibodies ResearchMedicine3.8%
- Immune cells in cancerImmunology and Microbiology3.7%
- CAR-T cell therapy researchMedicine3.7%
- Asthma and respiratory diseasesMedicine3.6%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 免疫学IMMUNOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 免疫学IMMUNOLOGY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 免疫学IMMUNOLOGY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Web of SciencePMCPubMed出版商官网
其他：Google Scholar、Crossref
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 5.81LetPub ·
- CiteScore 2026-06
- 9.3LetPub ·
- SJR 2026-06
- 1.73LetPub ·
- SNIP 2026-06
- 1.16LetPub ·
- h-index
- 11LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 498OpenAlex ·
- 两年平均被引
- 9.36OpenAlex ·
- 自引率
- 5.1%LetPub ·
- Gold OA 文章占比
- 99.22%LetPub ·
发文规模
- 年文章数
- 42LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,047 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 35 | 35 | 45 |
| 2025 | 44 | 44 | 362 |
| 2024 | 45 | 45 | 754 |
| 2023 | 46 | 46 | 656 |
| 2022 | 51 | 51 | 1,166 |
| 2021 | 45 | 45 | 1,182 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
63 天投稿到接收中位数 · P25–P75 39 天 – 99 天
- 接收到上线
- 中位数 28 天（78 篇）
- 投稿到上线
- 中位数 89 天
- 样本
- 78 篇有投稿与接收日期的文章（窗口内共 79 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取OpenAlex
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | USD 1,000 / USD 1,200 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型12 种，含篇幅限制
- brief communicationOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …正文 ≤ 150 词 · 摘要 ≤ 150 词 · 图表 ≤ 4
- brief communicationsBrief communications are short articles reporting findings of immediate impact.未说明篇幅
- correspondencesCorrespondences serve as a platform for the rapid exchange of opinions, views, or responses to previously published research.未说明篇幅
- editorialOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …图表 ≤ 1
- editorialsEditorials are invited perspectives aiming to provide new insights into active fields of immunological research.未说明篇幅
- letterOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …未说明篇幅
- opinionOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …未说明篇幅
- original articleOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …正文 ≤ 200 词 · 摘要 ≤ 200 词 · 图表 ≤ 7
- original articlesOriginal articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies.未说明篇幅
- perspectiveOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …未说明篇幅
- review articleOriginal Articles Original articles are full-length papers describing novel findings across all areas of immunology, including both basic and clinical studies. …正文 ≤ 200 词 · 摘要 ≤ 200 词 · 图表 ≤ 1
- review articlesReview articles are full-length papers aiming to provide new frameworks for recent findings, or balanced views of a field or topic.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用
Generative AI use allowed with disclosure; AI tools must not be listed as authors. 模型摘要
Authors may use generative AI tools to assist in preparing their manuscripts.
原文 ↗出版商官网 ·- 作者资格 7. Author Contributions
ORCID ID of corresponding author required. 模型摘要
Enter all author contributions in the submission system during submission. The contributions of all authors must be described using the CRediT Taxonomy of author roles. To qualify for authorship, all contributors must meet at least one of the seven core contributions (conceptualization, methodology, software, validation, formal analysis, investigation, data curation), as well as at least one of th…
原文 ↗出版商官网 ·- 利益冲突 5. Conflicts of Interest
Conflicts of interest should be disclosed following the acknowledgements section. Disclosure of conflicts of interest must be followed by the guidelines described in Ethical Policy. 6. Artificial Intelligence (AI) Usage Disclosure • Authors may use generative AI tools to assist in preparing their manuscripts. • Authors remain fully responsible for the accuracy, originality, integrity, and scientif…
原文 ↗出版商官网 ·- 许可与版权 Copyright Transfer
All manuscripts are considered to be the property of KAI from the time of submission. Manuscripts published in Immune Network become the sole property of KAI with all copyrights reserved to KAI. The corresponding author, on behalf of all authors, must sign the Copyright Transfer Form, and return it to journal office, before publication. Authors reusing their own material do not need to contact KAI…
原文 ↗出版商官网 ·- 开放获取 Open Access
Deposits all published articles into PMC since 2009. 模型摘要
Immune Network is an open access journal. Full-text and PDF are freely available from the journal homepage, https://immunenetwork.org. Publication Fees Publication fees have to be paid before publication. An invoice will be issued to the corresponding author upon acceptance. If the authors do not agree to pay, the Editorial Office may cancel the acceptance of the manuscript. Publication fees for i…
原文 ↗出版商官网 ·- 同行评审 2. Peer Review Information
90 days to submit a revision. 模型摘要
1) Peer Review Process By submitting a manuscript to Immune Network, the authors agree to subject it to a confidential peer review process. Editors and reviewers are informed that the manuscript must be considered confidential. After a manuscript is received, it is assigned by Editor-in-Chief to a specific Deputy Editor, whose expertise is considered to be appropriate. The Deputy Editor selects at…
原文 ↗出版商官网 ·- 预印本 Preprints
Preprints allowed at any time during peer review; not considered prior publication. 模型摘要
Immune Network encourages posting of preprints of primary research manuscripts on a community preprint servers such as bioRxiv. Preprints may be posted at any time during the peer review processes. Manuscripts posted to preprint server are not considered prior publication, nor are presentations of a work at a conference. Authors who post their work as a preprint should identify the preprint server…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Korean Association of Immunologists
- 出版国家或地区
- South Korea
- 出版语言
- English
- ISSN
- 1598-2629
- 电子版 ISSN
- 2092-6685
- 学会 / 主办单位
- Korean Association of Immunologists
- 官网最新一期
- Volume 26, Issue 4（2026 年 8 月）
常见问题
关于 Immune Network 的常见问题
Immune Network 是中科院几区期刊？
2025 年升级版分区表中，Immune Network 为医学 4区，小类 免疫学 4 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Immune Network 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 5.81，CiteScore 为 9.3，h-index 为 69。
Immune Network 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）78 篇已发表文章登记的日期，投稿到接收的中位数为 63 天（四分位 39–99 天）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Immune Network 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 72 位编委中，中国大陆 2 位（约 3%）；人数最多的国家是 韩国（40 位）、美国（16 位）、日本（5 位）。统计按编委会页面列出的机构国家计，仅供参考。
Immune Network 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Immune Network 被 SCIE、Scopus 收录。期刊官网自述还被 Web of Science、PMC、PubMed 收录，该清单未与各数据库逐一核对。
Immune Network 是开放获取期刊吗？版面费多少？
Immune Network 为完全开放获取。APC 约 1,000 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。